NCT04187326

Brief Summary

High trait anxiety, a stable personality trait, is a risk factor for psychiatric disorders. Individuals with high trait anxiety have difficulty differentiating safety from threat, including visual information like emotional faces. This study aims to characterize visual system function in high trait anxiety. A portion of this study involves an intervention. For the intervention portion, a subset of participants will be asked to return for a lab visit upon completing the first portion of the study (multimodal magnetic resonance imaging (MRI) scan). During this follow up visit, participants will complete a computer task that involves looking at faces and identifying emotions. Participants will complete this task either six months or twelve months after their MRI scan visit. Results from this research have the potential to inform novel therapies that target the visual system in individuals at risk for the development of psychiatric disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 5, 2019

Completed
1.2 years until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

September 4, 2025

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

3 years

First QC Date

December 3, 2019

Results QC Date

July 4, 2025

Last Update Submit

August 15, 2025

Conditions

Keywords

visual processing

Outcome Measures

Primary Outcomes (1)

  • Tolerability of the Micro Expression Training Task in Individuals With High Anxiety

    Rates of completion of the behavioral task

    six or twelve months post-scan visit

Study Arms (2)

6 Month Micro Expression Training Task

EXPERIMENTAL

The Micro Expression Training Task (METT) presents videos of subtle emotional face expressions; participants receive real-time feedback following forced choice emotional identification. The METT includes a brief pre-test, training, and then a post-test.

Behavioral: Facial Microexpression Training

12 Month Micro Expression Training Task

EXPERIMENTAL

The Micro Expression Training Task (METT) presents videos of subtle emotional face expressions; participants receive real-time feedback following forced choice emotional identification. The METT includes a brief pre-test, training, and then a post-test. Participants in this group will complete this task twelve month after their first visit.

Behavioral: Facial Microexpression Training

Interventions

The METT is a well-validated task designed to improve perception of subtle changes in facial expressions, termed microexpressions. Participants with high trait anxiety will return to the lab approximately six months post scan visit to complete this computer-based task. They will receive feedback during the task on their accuracy.

12 Month Micro Expression Training Task6 Month Micro Expression Training Task

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Young adults varying continuously in trait anxiety as assessed by the Spielberger State Trait Anxiety Inventory (STAI).
  • HTA participants with STAI trait scores of ≥44

You may not qualify if:

  • contraindication to MRI
  • history of head trauma or loss of consciousness
  • major medical or neurological illness
  • current psychiatric medication usage or use in the last three months
  • alcohol/substance abuse or dependence and/or illicit substance use (excepting cannabis) in the last three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Massachusetts Chan School of Medicine

Worcester, Massachusetts, 01655, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Results Point of Contact

Title
Dr. Elliot Edmiston, Associate Professor of Psychiatry & Behavioral Sciences
Organization
UMass Chan School of Medicine

Study Officials

  • Elliot K Edmiston, PhD

    Associate Professor

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study team will use a waitlist-control design. A subset of participants will return to complete visual training using the Micro Expression Training Tool (METT). Half of these participants will complete the task at their first follow up visit (approximately six months post scan), and half will complete the task at their second follow up visit (approximately twelve months post scan). The METT presents videos of micro expressions; participants receive real-time feedback following forced choice emotional identification. The METT includes a brief pre-test, training, and then a post-test. We will collect performance accuracy data. This behavioral task will provide preliminary feasibility data for the development of interventions with visual system targets by helping the investigators determine if the METT is tolerable in individuals with high trait anxiety.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 3, 2019

First Posted

December 5, 2019

Study Start

March 1, 2021

Primary Completion

March 15, 2024

Study Completion

March 15, 2024

Last Updated

September 4, 2025

Results First Posted

September 4, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations